Peripheral B cell alteration in patients with premature ovarian insufficiency

卵巢早衰患者外周血B细胞改变

阅读:1

Abstract

Premature ovarian insufficiency (POI) is one of the most common diseases contributing to declining fertility globally. Autoimmune dysregulation has been implicated in POI, but the role of B cell and its subsets in immune dysregulation in POI remains unclear. In the current study, we investigated whether disturbances in the distribution and functional characteristics of peripheral B cell subsets are associated with POI and its severity. Our results revealed that POI patients exhibited a higher percentage of total CD19(+) B cells, but the proportion of memory B cells (MBCs) and plasmablasts was significantly reduced compared to controls. A notable decrease in interleukin-10 (IL-10) production by B cells was observed, primarily due to a reduction in CD19(+)CD24(hi)CD27(+) and CD19(+)CD24(hi)CD38(hi) regulatory B cells (B(regs)). These alterations correlated with elevated follicle-stimulating hormone (FSH) and decreased anti-Müllerian hormone (AMH) and antral follicle count (AFC) levels. However, no significant differences were observed in the suppressive capacity of B(regs) on interferon-gamma (IFN-γ) or tumor necrosis factor-alpha (TNF-α) production by autologous CD4(+) T cells in POI patients compared with control women. These findings suggest that B-cell dysregulation may contribute to the immune pathogenesis of POI, providing potential targets for therapeutic intervention.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。